Article PDF
References
Jick, H.;Miettjnen, O.S.;Shapiro, S.;Lewis, G. P.;Siskind, V.; &Slone, D. Comprehensive drug surveillance J.A.M.A.,213: 1455 (1970).
Forney, R. B. Drug interaction. Proceedings of the 23rd Postgraduate Assembly in Anesthesiology., Dec. 1969, New York, N.Y.
MacGrecor, A. G.,et al. Symposium on interaction drugs, Proc. Roy. Soc. Med.,58: 943 (1965).
Morrelli, H. F. &Melmon, K. L. The clinician's approach to drug interactions. Calif. Med.,109: 380 (1968).
Prescott, L. F. Pharmacokinetic drug interactions. Lancet,2: 1239 (1969).
Hunninghake, D. B. Drug interactions. Postgrad, Med.,47: 71 (1970).
Pharmacology for the preoperative visit. Int. Anesth. Clin., Vol. 6, Edit. Gravenstein, J.S., Little, Brown and Company, 1968.
Jenkins, L. C. The interaction of drugs, with particular reference to anaesthetic practice. Canad. Anaesth. Soc. J.,15: 111 (1968).
Cheymol, J.;Bourillet, F.; &Levassort, C. Action anticurarimimetique de l'héparine et d'héparionoide de syntèse chez le lapin. J. physiol. Paris,47: 132 (1955).
Ariëns, E. J. Ciba foundation study group No. 12. Curare and Curare-like agents. Edited by A. V. S. De Reuck, Boston: Little, Brown and Company, 1962.
Kunin, C. M. &Finland, M. Clinical pharmacology of the tetracycline antibiotics. Clin. Pharmacol. Ther.,2: 51 (1961).
Parker, E. A. Parenteral incompatibilities. Hosp. Pharmac.,4: 14, 1969.
Hogben, C. A. M.;Tocco, D. J.;Brodie, B. B.; &Schanker, L. S. On the mechanism of intestinal absorption of drugs. J. Pharmacol. & Exper. Therap.,125: 275 (1959).
Small, M. D.;Folen, V.;Abrams, G.;Bledsoe, F.,et al. High doses of neomycin sulfate and the absorption of glucose and xylose from the rat small intestine. Am. J. Dig. Dis.11: 923 (1966).
Hvidt, S.; &Kjeldsen, K. Malabsorption induced by small doses of neomycin sulfate. Acta. Med. Scand.,173: 699 (1963).
Adriani, J.; &Zepernick, R. Some recent studies on clinical pharmacology of local anaesthetics of practical significance. Ann. Surg.,158: 666 (1963).
Moore, D. C. Evaluation of hyaluronidase in local and nerve block analgesia. Anesthesiology,11: 470 (1950).
Eger, E. I., ii. Respiratory and circulatory factors in uptake and distribution of volatile anaesthetic agents. Brit. J. Anaesth.,36: 155 (1964).
Inkster, J. S. The induction of anaesthesia in patients likely to vomit with special reference to intestinal obstruction., Brit. J. Anaesth.,35: 160 (1963).
Epstein, R. M.;Rackow, H.;Salanitre, E.;et al. Influence of the concentration effect on the uptake of anaesthetic mixtures: The second gas effect. Anesthesiology,25: 364 (1964).
Stoelting, R. K.;Ecer, E. I. ii. An additional explanation for the second gas effect. A concentrating effect. Anesthesiology,30: 273 (1969).
Goldstein, A. The interaction of drugs and plasma proteins. Pharmacol. Rev.,1: 102 (1949).
Goldstein, A.;Aronow, L.; &Kalman, S. M. Principles of drug action. The basis of pharmacology. New York, Harper & Row, 1969.
Brodie, B. B. Displacement of one drug by another from carrier or receptor sites. Proc. Roy. Soc. Med.,58: 946 (1965).
Welch, R. M.;Harrison, Y. E.;Conney, A. H.; &Burns, J. J. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin. Clin. Pharmacol. Ther.,10; 817 (1969).
Sellers, E. M.; &Koch-Weser, J. Potentiation of Warfarin-induced hypoprothrombinemia by chloral hydrate., New Eng. J. Med.,283: 827 (1970).
Dal Santo, G. Kinetics of distribution of radioactive-labeled muscle relaxants: i. Investigations with C14 dimethyl-d-tubocurarine., Anesthesiology,25: 788 (1964).
Dal Santo, G. Kinetics of distribution of radioactive-labeled muscle relaxants: iii. Investigations with C14 succinyldicholine and C14 succinylmonocholine during controlled conditions. Anesthesiology,29: 435 (1968).
Usubiaga, J. E.;Wikinski, J. A.;Morales, R. L.,et al. Interaction of intravenously administered procaine, lidocaine and succinylcholine in anaesthetized subjects. Anesth. & Analg.,46: 39 (1967).
Richards, R. K.; &Taylor, J. D. Some factors influencing distribution, metabolism and action of barbiturates: A Review. Anesthesiology,17: 414 (1956).
Lasser, E. C.;Elizondo-Martel, G.; &Granke, R. C. Potentiation of pentobarbital anaesthesia by competitive protein binding. Anesthesiology,24: 665 (1963).
Laasberg, L. H.; &Hedley-Whyte, J. Halothane solubility in blood and solutions of plasma proteins. Anesthesiology,32: 351 (1970).
Laasberg, L. H. & Hedley-Whyte, J. Pørsonal Communication.
Waud, D. R. Pharmacological receptors. Pharmacol. Rev.,20: 49 (1968).
Furchgott, R. F. Receptor mechanisms. Ann. Rev. Pharm.,4: 21 (1964).
Ariëns, E. J.;Van Rossum, J. M.; &Simonis, A. M. Affinity, intrinsic activity and drug interaction. Pharmacol. Rev.,9: 218 (1957).
Bellville, J. W.; &Fleischli, G. The interaction of morphine and nalorphine on respiration. Clin. Pharm. & Therap.,9: 152 (1968).
Rouge, J. C.;Banner, M. P.; &Smith, T. C. Interactions of levallorphan and meperidine. Clin. Pharm. & Therap.,10: 643 (1969).
Ghoneim, M. M. &Long, J. P. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology,32: 23 (1970).
Veldstra, H. Synergism and potentiation. Pharmacol. Rev.,8: 339 (1956).
Chagas, C. Ciba foundation Study group No. 12. Curare and curare-like agents. Edited by A. V. S. DeReuck. Boston: Little, Brown and Company, 1962.
Milne, M. D. Influence of acid-base balance on efficacy and toxicity of drugs. Proc. Roy. Soc. Med.,58: 961 (1965).
Wilkinson, C. R. &Beckett, A. H. Absorption, metabolism and excretion of the ephedrines in man. 1. The influence of urinary pH and urine volume output. J. Pharmacol. & Exper. Therap.,162: 139 (1968).
Beckett, A. H.;Salmon, J. A.; &Mitchard, M. The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [C14] amphetamind] J. Pharm. & Pharmacol.21: 251 (1969).
Freeman, J. The renal and hepatic circulations in anaesthesia. Ann. Roy. Col. Surgeons England,46: 141 (1970).
Albert, A. Ionization, pH and biological activity. Pharmacol. Rev.4: 136 (1952).
Waddel, W. J. &Butler, T. C. The distribution and excretion of phenobarbital. J. Clin. Invest.,36: 1217 (1957).
Roth, L. J. &Barlow, C. F. Drugs in the brain. Science,134: 21 (1961).
Goldberg, M. A.;Barlow, C. F.; &Roth, L. J. THe effects of carbon dioxide on the entry and accumulation of drugs in the central nervous system. J. Pharmacol. & Exper. Therap.,131: 308 (1961).
Ritchie, J. M. &Ritchie, B. R. Local anaesthetics: Effect of pH on activity. Science,162: 1394 (1968).
Ritchie, J. M. &Greengard, P. On the active structure of local anaesthetics. J. Pharmacol. & Exper. Therap.,133: 241 (1961).
Lofstrom, B. Aspects of the pharmacology of local anaesthetic agents. Brit. J. Anaesth.,42: 194 (1970).
Bonica, J. J.;Backup, P. H.;Anderson, C. E.;Hadfield, D.;Crepps, W. F.; andMonk, B. F. Peridural block: Analysis of 3,637 cases and a review, Anesthesiology,18: 723 (1957).
Rochae Silva, M. Influence of pH on the interaction of histamine with its receptors in the guinea pig ileum. Arch. internat. pharmacodyn.,128: 355 (1960).
Ariëns, E. J. &Simonis, A. M. pH and drug action. Arch. internat. pharmacodyn.,141: 309 (1963).
Beckett, A. H. &Greenhill, J. V. Weakly basic analogues of potent analgesies. J. Med. Pharm. Chem.,4: 423 (1961).
Biers, H. &Stevenson, G. W. The active form of the narcotic analgesic molecule. Federation Proc.,19: 272 (1960).
Baraka, A. The influence of carbon dioxide on the neuromuscular block caused by tubocurarine chloride in the human subject. Brit. J. Anaesth.,36: 272 (1964).
Bromace, P. R. Physiology and pharmacology of epidural analgesia. Anesthesiology,28: 592 (1967).
Burns, J. J. &Conney, A. H. Enzyme stimulation and inhibition in the metabolism of drugs. Proc. Roy. Soc. Med.,58: 955 (1965).
Welch, R. M.;Harrison, Y. E.;Conney, A. H.,et al. Cigarette smoking: Stimulatory effect on metabolism of 3, 4-benzpyrene by enzymes in human placenta. Science,160: 541 (1968).
Rubin, E. &Lieber, C. S. Hepatic microsomal enzymes in man and rat: Induction and inhibition by ethanol. Science,162: 690 (1968).
Mitoma, C.;Sorich, T. J. ii; &Neubauer, S. E. The effect of caffeine on drug metabolism. Life Sci.,7: 145 (1968).
Burns, J. J. Interaction of environmental agents and drugs. Environ. Res.,2: 352 (1969).
Fouts, J. R. &Rogers, L. A. Morphological changes in the liver accompanying stimulation of microsomal drug metabolizing enzyme activity by phenobarbital, chlordane, benzpyrene or methylcholanthrene in rats. J. Pharmacol. Exper. & Therap.,147: 112 (1965).
Cucinell, S. A.;Conney, A. H.;Sansur, M.; &Burns, J. J. Drug interactions in man. 1. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin and diphenylhydautoin. Clin. Pharm. Ther.,6: 420 (1965).
Cucinell, S. A.;Koster, R.;Conney, A. H.; &Burns, J. J. Stimulatory effect of phenobarbital on the metabolism of diphenylhydantoin. J. Pharmacol. & Exper. Therap.;141: 157 (1963).
Werk, E. E., Jr.;MacGee, J.; &Sholiton, L. J. Effect of diphenylhydantoin on cortisol metabolism in man. J. Clin. Invest.,43: 1824 (1964).
Yeung, C. Y. &Field, C. E. Phenobarbitone therapy inonconnatal hyperbilirubinaemia. Lancet,2: 135 (1969).
Werk, E. E., Jr.;Sholitan, L. J.; &Olinger, C. P. Amelioration of nontumorous Cushing's syndrome by diphenylhydantoin. International Congress Series No.III. Second International Congress on hormonal steroids. Amsterdam, Excerpta Medica Foundation, 1966.
Piel, M. T.;Aldrete, J. A.; &Jones, G.. Influence of enzyme induction on the sleeping time of rats. Canad. Anaesth. Soc. J.,16: 538 (1969).
Van Dyke, R. A. Metabolism of volatile anaesthetics.III. Induction of microsomal dechlorinating and ether-cleaving enzymes. J. Pharmacol. & Exper. Therap.,154: 364 (1966).
Berman, M. L. &Bochantin, J. F. Non-specific stimulation of drug metabolism in rats by methoxyflurane. Anesthesiology,32: 500 (1970).
Remmer, H. Drugs as activators of drug enzymes. In Proceedings of the first international pharmacological meeting, Stockholm, Vol.VI. Metabolic factors controlling duration of drug action. Ed. by B. B. Brodie and E. G. Erdos. New York: Pergamon Press, 1962.
Cohen, E. N. Metabolism of halothane-2 C14 in the mouse, Anesthesiology,31: 560 (1969).
Artusio, J. F. Discussion. Liver failure after repeated use rekindles halothane safety debate. J.A.M.A.,207: 2197 (1969).
Dorfman, A. &Goldbaum, L. R. Detoxification of barbiturates. J. Pharmacol. & Exper. Therap.,90: 330 (1947).
Cooper, J. R. &Brodie, B. B. Enzymatic oxidation of pentobarbital and thiopental. J. Pharmacol. Exper. Therap.,120: 75 (1957).
Gilman, A. G. &Conney, A. H. The induction of amino azodye N-demethylase in non hepatic tissues by 3-methylcholanthrene. Biochem. Pharmacol.,12: 591 (1963).
Remmer, H. Hemmung und Steigerung mikrosomaler oxydationen durch Körpereigene und Körperfremde Staffe In: Redoxfunktionen cytoplasmatischer Strukturen Symposium, Wieur. Wiener Akademie für Ärztliche Forbildung, Wien 1962.
Uehleke, H. Extra hepatic microsomal drug metabolism. In Proceedings of the European Society for the study of drug toxicity, Vol. x. Sensitization to drugs. Ed. Baker, S. B. & Tripod, J. Excerpta Medica foundation, Amsterdam, 1969.
Levi, A. J.;Sherlock, S.; &Walker, D. Phenylbulazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet,1: 1275 (1968).
Kolmodin, B.;Azarnoff, D. L.; &Sjöqvist, F. Effect of environmental factors on drug metabolism: Decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides. Clin. Pharmacol. & Therap.,10: 638 (1969).
Veseli, E. S. &Page, J. G. Genetic control of drug levels in man: Phenylbutazone. Science,159: 1479 (1968).
Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences — National Research Council. Clin. Pharmacol. & Therap.,10: 607 (1969).
Clouet, D. H. Meperidine N-demethylase activity in rat liver. J. Pharmacol. & Exper Therap.,144: 354 (1964).
Baekland, F. &Greene, N. M. Effect of diethyl ether on tissue distribution and metabolism of pentobarbital in rats. Anesthesiology,19: 724 (1958).
Hulpieu, H. R. &Colf, V. V. Effects of thiopental sodium, chloroform, and diethyl ether on metabolism and toxicity of procaine. J. Pharmacol. & Exper. Therap.,99: 370 (1950).
Adams, H. R. &Dixit, B. N. Prolongation of pentobarbital anaesthesia by chloramphenicol in dogs and cats. J. A. V. M. A.,156: 902 (1970).
Hansen, J. M.;Kristensen, M.;Skovsted, L.; &Christensen, L. K. Dicumarol-induced diphenylhydantoin intoxication. Lancet,2: 265 (1966).
Christensen, L. K. &Skovsted, L. Inhibition of drug metabolism by chloramphenicol. Lancet,2: 1397 (1969).
Greene, N. M. The metabolism of drugs employed in anesthesia. Part 1. Anesthesiology,29: 127 (1968).
Eilderton, T. E.;Farmati, O.; &Zsigmond, E. K. Reduction in plasma cholinesterase levels after prolonged administration of echothiophate iodide eye drops. Canad. Anaesth. Soc. J.,15: 291 (1968).
Jenkins, L. C. &Graves, H. B. Potential hazards of psychoactive drugs in association with anaesthesia. Canad. Anaesth. Soc. J.,12: 121 (1965).
Gorkin, V. Z. Monoamine oxidases. Pharm. Rev.,18: 115 (1966).
Pletscher, A. Monoamine oxidase inhibitors. Pharm. Rev.,18: 121 (1966).
Sjöqvist, F. Psychotropic drugs (2). Interaction betweenMAO inhibitors and other substances. Proc. Roy. Soc. Med. London,58: 967 (1965).
Certner, S. B. The effects of monoamine oxidase inhibitors on ganglionic transmission. J. Pharmacol. & Exper. Therap.,131: 223 (1961).
Kopin, I. J.;Fischer, J. F.;Musacchio, J.; &Horst, W. D. Induction of false neurochemical transmitters as a mechanism for the sympathetic blocking action of monoamine oxidase inhibitors. Pharmacologist,6: 175 (1964).
Allen, G. S. &Rand, M. J. Interaction between histamine and monoamine oxidase inhibitors. J. Pharm. & Pharmacol.,21: 317 (1969).
Rogers, K. J. &Thornton, J. A. The interaction between monoamine oxidase inhibitors and nucotic analgesics in mice. Brit. J. Pharmacol.,36: 470 (1969).
Taylor, D. C. Alarming reaction to pethidine in patients on phenelzine. Lancet,2: 401 (1962).
Cessner, P. K. &Soble, A. G. Studies on the role of brain 5-HT in the interaction between tranylcypromine and meperidine. Fed. Proc.,29; 685 (1970).
Summers, R. J. Effects of monoamine oxidase inhibitors on the hypothermia produced in cats by halothane. Brit. J. Pharmacol.,37: 400 (1969).
Feldberg, W. &Lotti, V. J. Body temperature responses in cats and rabbits to the monoamine oxidase inhibitor tranylcypromine. J. Physiol.,190: 203 (1967).
Feldberg, W. &Lang, W. J. Effects of monoamine oxidase inhibitors and amphetamine on hypothermia produced by halothane. Brit. J. Pharmacol.,38: 181 (1970).
Horsey, P. J. Hyperpyrexia during anaesthesia. Brit. Med. J.,3: 803 (1968).
Britt, B. A. &Kalow, W. Malignant hyperthermia: Aetiology unknown! Canad. Anaesth. Soe. J.,17: 316 (1970).
Coldstein, M.;Anagnoste, B.;Lauber, E.; &McKereghan, M. R. Inhibition of dopamine-beta-hydroxylase by disulfiram. Life Sci.,3: 763 (1964).
Anton, A. H. In Gravenstein, J. S. (Ed.) Pharmacology for the preoperative visit. Int. Anaesth. Clin.,6: 312–314 (1968).
Warner, W. Beta-adrenergic blocking agents and anaesthesia: A Review. Canad. Anaesth. Soc. J.,15: 42 (1968).
Simpson, L. L. Personal communication (in press).
Council on drugs: Fixed-dose combinations of drugs. J.A.M.A.,213: 1172 (1970).
Weiner, M. Drug interaction. New Eng. J. Med.,283: 871 (1970).
Venn, R. D. Experience with the collection and evaluation of drug adverse reaction data. In Proceedings of the European Society for the Study of drug toxicity. Vol. x.. Excerpta Medica Foundation. Amsterdam, 1969.
Slone, D.;Jick, H.;Lewis, G. P.et al. Intravenously given ethacrynic acid and gastrointestinal bleeding. J.A.M.A.,209: 1668 (1969).
DeHaen, P. Problems in information handling on drug interactions. A paper presented at the fifth annual meeting of drug information association. Detroit. Michigan, May, 1969.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghoneim, M.M. Drug interaction in anaesthesia a review. Canad. Anaesth. Soc. J. 18, 353–375 (1971). https://doi.org/10.1007/BF03025688
Issue Date:
DOI: https://doi.org/10.1007/BF03025688